<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HC4BA615917794DA181D3F94A3A056ED8" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 3595 IH: Safe Prescribing Through Reporting Act of 2025</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-05-23</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 3595</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250523">May 23, 2025</action-date><action-desc><sponsor name-id="K000403">Mr. Kennedy of Utah</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Public Health Service Act to provide for the disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programs, and for other purposes.</official-title></form><legis-body id="HB990C35290B142B7B355F7752FE03072" style="OLC"> 
<section id="HA6E990DD33D142319F01E26AD48332B0" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Safe Prescribing Through Reporting Act of 2025</short-title></quote>.</text></section> <section id="H7C70FFF699AF466CBDBBA04AEEA58B53"><enum>2.</enum><header>Disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programs</header><text display-inline="no-display-inline">Section 543(b)(2) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290dd-2">42 U.S.C. 290dd–2(b)(2)</external-xref>) is amended by adding at the end the following:</text>
<quoted-block style="OLC" id="HFB42F99655B34E15B93DF42109AE010A" display-inline="no-display-inline">
<subparagraph id="H50C7D1F4270C40BC943A4BEEEB116936"><enum>(E)</enum><text display-inline="yes-display-inline">To the applicable prescription drug monitoring program of a State if—</text> <clause id="HEAD458A314224A80A1F78F2BF7F90950"><enum>(i)</enum><text>such record relates to the prescribing or dispensing of a substance use disorder medication; and</text></clause>
<clause id="H66DDCFB168544969962D40F922C28831"><enum>(ii)</enum><text>such disclosure is required by applicable State law.</text></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block> </section> </legis-body></bill>

